MBRX · Forms 3, 4, 5
Insider trades at Moleculin Biotech, Inc.
3 insiders bought $0 of Moleculin Biotech, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Moleculin Biotech, Inc. (MBRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Donald H Picker | Chief Science Officer | Options or other derivatives | Form 4 | ||||
| Walter V Klemp | CEO and President | Option exercise | 207,500 | Form 4 | |||
| Walter V Klemp | CEO and President | Tax withholding | 48,659 | $0.37 | $18K | Form 4 | |
| Jonathan P. Foster | Chief Financial Officer | Option exercise | 130,000 | Form 4 | |||
| Jonathan P. Foster | Chief Financial Officer | Tax withholding | 30,485 | $0.37 | $11K | Form 4 | |
| Jonathan P. Foster | Chief Financial Officer | Buy | 293,333 | Form 4 | |||
| Walter V Klemp | CEO and President | Buy | 533,333 | Form 4 | |||
| Donald H Picker | Chief Science Officer | Buy | 173,333 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.